10YR企业会员
英文名称 | 中文名称 | CAS |
---|---|---|
IDO-IN-7(Navoximod) | IDO-IN-7抑制剂 | 1402837-78-8 |
GPR40 agonist 4 | 2-[[4-[(2'-氯[1,1'-联苯]-3-基)甲氧基]苯基]磺酰基]乙酸 | 2102196-57-4 |
Elacridar hydrochloride | 依克立达盐酸盐 | 143851-98-3 |
Letermovir | 乐特莫韦 | 917389-32-3 |
Dasotraline hydrochloride | 达索曲林盐酸盐 | 675126-08-6 |
PIK-90 | N-(2,3-二氢-7,8-二甲氧基咪唑并[1,2-C]喹唑啉-5-基)-3-吡啶甲酰胺 | 677338-12-4 |
CDKI-73 | CS-2259 | 1421693-22-2 |
DGY-06-116 | DGY-06-116 | 2556836-50-9 |
IM156 | IM156 | 1422365-93-2 |
AM-2394 | AM2394 | 1442684-77-6 |
MK-3903 | MK-3903 | 1219737-12-8 |
(±)-BAY-1251152 | 1610358-53-6 | 1610358-53-6 |
ML365 | ML-365 | 947914-18-3 |
Verinurad | 维立诺雷 | 1352792-74-5 |
HG-10-102-01 | [4-[[5-氯-4-(甲基氨基)-2-嘧啶基]氨基]-3-甲氧基苯基]-4-吗啉基甲酮 | 1351758-81-0 |
EX229 | EX229 | 1219739-36-2 |
GSK6853 | GSK6853 | 1910124-24-1 |
Benzoic acid, | 3-(3-(4-(2,4,4-三甲基戊-2-基)苯氧基)丙酰胺基)苯甲酸甲酯 | 2143473-95-2 |
Opicapone | 奥匹卡朋 | 923287-50-7 |
FIT-039 | FIT-039 | 1113044-49-7 |
JTE 013 | JTE-013 | 383150-41-2 |
GSK-843 | GSK-843 | 1601496-05-2 |
CGP 60474 | 3-((4-(2-((3-氯苯基)氨基)嘧啶-4-基)吡啶-2-基)氨基)丙-1-醇 | 164658-13-3 |
NIK SMI1 | NIK SMI1 | 1660114-31-7 |
TRC253 | CS-2727 | 2110426-27-0 |
JNJ40411813 | JNJ40411813 | 1127498-03-6 |
JNJ-42165279 | N-(4-氯-3-吡啶基)-4-[(2,2-二氟-1,3-苯并二恶茂-5-基)甲基]-1-哌嗪甲酰胺 | 1346528-50-4 |
THZ531 | THZ531 | 1702809-17-3 |
THZ2 | THZ2 | 1604810-84-5 |
Dibenzazepine | 二苯并氮卓 | 209984-56-5 |
GDC0575 | (R)-N-(4-(3-氨基哌啶-1-基)-5-溴-1H-吡咯并[2,3-B]吡啶-3-基)环丙烷甲酰胺 | 1196541-47-5 |
BVT948 | 4-羟基-3,3-二甲基-2H-苯并[G]吲哚-2,5(3H)-二酮 | 39674-97-0 |
TRULI | 1H-Pyrrolo[2,3-b]pyridine-3-carboxamide, N-[3-(phenylmethyl)-2(3H)-thiazolylidene]- | 1424635-83-5 |
Irbinitinib (ARRY-380) | 妥卡替尼 | 937263-43-9 |
J-14 | J-14 | 1043854-13-2 |
Elacridar | 依克立达 | 143664-11-3 |
WAY-181187(SAX-187) | WAY 181187 | 554403-49-5 |
Amifloxacin | 氨氟沙星 | 86393-37-5 |
Compound A | 10MG | 1665301-36-9 |
DM1-SMe | N2'-去乙酰基-N2'-[3-(甲基二硫基)-1-氧代丙基]美登素 | 138148-68-2 |
4-ACRYLAMIDOBENZO-18-CROWN-6, 98 | 4-丙烯酰胺苯并-18-冠醚 | 68865-32-7 |
5-chloro-2,3-dihydro-benzofuran-3-ol | 5590-44-3 | |
5-CHLORO-2,3-DIHYDRO-BENZOFURAN-3-YLAMINE | 5-氯-2,3-二氢苯并呋喃-3-胺 | 769-21-1 |
Lys-SMCC-DM1 | Lys-SMCC-DM1 | 1281816-04-3 |
PLX4032 (Vemurafenib) | 维罗非尼 | 918504-65-1 |
EPZ015866,GSK3203591 | GSK591 (EPZ-015866) | 1616391-87-7 |
UK-371804 | 化合物UK371804 | 256477-09-5 |
MKC3946 | 1093119-54-0 | 1093119-54-0 |
Acebilustat | 阿西鲁司特 | 943764-99-6 |
BDA-366 | 1-[[(2S)-3-(二乙基氨基)-2-羟基丙基]氨基]-4-[[(2S)-2-环氧乙烷基甲基]氨基]-9,10-蒽醌 | 1909226-00-1 |
CPI-637 | (R)-4-甲基-6-(1-甲基-3-(1-甲基-1H-吡唑-4-基)-1H-吲唑-5-基)-4,5-二氢-1H-苯并[B][1,4]二氮杂-2(3H)-酮 | 1884712-47-3 |
Onatasertib(CC 223,ATG-008) | CC-223 | 1228013-30-6 |
Grapiprant | GRAPIPRANT | 415903-37-6 |
ETP-46321 | CS-2500 | 1252594-99-2 |
CNV 1014802 hydrochloride | (2S,5R)-5-(4-((2-氟苄基)氧基)苯基)吡咯烷-2-甲酰胺盐酸盐 | 934240-31-0 |
STK16-IN-1 | 化合物STK16-IN-1 | 1223001-53-3 |
Fatostatin A Hydrobromide | FATOSTATIN | 298197-04-3 |
CP-609754 | CP-609754 | 1190094-64-4 |
ABT-639 | ABT-639 | 1235560-28-7 |
GDC-0084 | GDC-0084 | 1382979-44-3 |
UNC1215 | (2-(苯氨基)-1,4-亚苯基)双((4-(吡咯烷-1-基)哌啶-1-基)甲酮) | 1415800-43-9 |
PF03274167 | PF-3274167 | 900510-03-4 |
NVS-PAK1-1 | NVS-PAK1-1 | 1783816-74-9 |
Motolimod (VTX-2337) | 2-氨基-N,N-二丙基-8-(4-(吡咯烷-1-羰基)苯基)-3H-苯并[b]氮杂-4-甲酰胺 | 926927-61-9 |
SH-4-54 | SH-4-54 | 1456632-40-8 |
SUN11602 | 化合物SUN 11602 | 704869-38-5 |
(E)-3-(2-(1H-tetrazol-5-yl)vinyl)-6-fluoro-1H-indole | (E)-3-(2-(1H-四氮唑-5-基)乙烯基)-6-氟-1H-吲哚 | 1316695-35-8 |
faldaprevir | FALDAPREVIR | 801283-95-4 |
Bictegravir | 比克替拉韦 | 1611493-60-7 |
PF-573228 | 6-[(4-((3-(甲磺酰基)苄基)氨基)-5-三氟甲基嘧啶-2-基)氨基]-3,4-二氢-1H-喹啉-2-酮 | 869288-64-2 |
Blu-263 | Blu263 | |
Lanraplenib (GS-9876) | GS-9876 | 1800046-95-0 |
CB-103 | 6-[4-(叔丁基)苯氧基]吡啶-3-胺 | 218457-67-1 |
LACS-13909 | 4-Piperidinamine, 1-[3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl- | 2160546-07-4 |
Pexmetinib (ARRY-614) | PEXMETINIB | 945614-12-0 |
SHP099 | SHP-099游离 | 1801747-42-1 |
GSK046 | VERDINEXOR | 2474876-09-8 |
Lasmiditan hydrochloride | 613677-28-4 | 613677-28-4 |
Lasmiditan | 2,4,6-三氟-N-[6-[(1-甲基-4-哌啶基)羰基]-2-吡啶基]苯甲酰胺 | 439239-90-4 |
Ceapin-A7 | N-(1-(2,4-双(三氟甲基)苄基)-1H-吡唑-4-基)-5-(呋喃-2-基)异恶唑-3-甲酰胺 | 2323027-38-7 |
MRT 68921 dihydrochloride | 2080306-21-2 | 2080306-21-2 |
SC66 | (2E,6E)-2,6-二(4-吡啶基亚甲基)环己酮 | 871361-88-5 |
Semaxanib(SU5416) | Semaxanib | 194413-58-6 |
Adjudin(AF-2364) | 1-(2,4-二氯苄基)-1H-吲唑-3-碳酰肼 | 252025-52-8 |
Siramesine HCl | 西拉美新盐酸盐 | 224177-60-0 |
BD1063 2HCL | BD1063盐酸盐 | 206996-13-6 |
Amsilarotene (TAC-101) | 4-[[3,5-二(三甲基硅烷基)苯甲酰基]氨基]苯甲酸 | 125973-56-0 |
GDC-0214 | IJAK-381 | 1831144-46-7 |
TG4-155 | TG4-155 | 1164462-05-8 |
4-(3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl)-phenylamine | 4-(3,5-双(三氟甲基)-1H-吡唑-1-基)-苯胺 | 123066-64-8 |
ML348 | CS-2370 | 899713-86-1 |
CC-885 | CC885 | 1010100-07-8 |
Caroverine HCl | 盐酸卡罗维林 | 55750-05-5 |
BI-3406 | N-((R)-1-(3-氨基-5-(三氟甲基)苯基)乙基)-7-甲氧基-2-甲基-6-(((S)-四氢呋喃-3-基)氧基)喹唑啉-4-胺 | 2230836-55-0 |
A-966492 | A-966492 | 934162-61-5 |
Fevipiprant | 非维匹仑 | 872365-14-5 |
Darexaban | N-[2-羟基-6-(4-甲氧基苯甲酰氨基)苯基]-4-(4-甲基-1,4-二氮杂庚烷-1-基)苯甲酰胺 | 365462-23-3 |
AT-527 | L-Alanine, N-[[P(S),2'R]-2-amino-2'-deoxy-2'-fluoro-N,2'-dimethyl-P-phenyl-5'-adenylyl]-, 1-methylethyl ester | 1998705-64-8 |
ACTB-1003 | N-[4-[4-氨基-6-(甲氧基甲基)-7-(4-吗啉基甲基)吡咯并[2,1-f][1,2,4]三嗪-5-基]-2-氟苯基]-N'-[2-氟-5-(三氟甲基)苯基]脲 | 939805-30-8 |
MRTX-1257 | MRTX-1257 | 2206736-04-9 |
联系方式